Ryusuke Yoshimi Selected Research

Rheumatoid Arthritis

5/2023	Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI).
1/2022	Current State and Issues of Regenerative Medicine for Rheumatic Diseases.
11/2021	Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis.
11/2019	Dose down-titration of biological disease-modifying antirheumatic drugs in daily clinical practice: Shared decision-making and patient treatment preferences in Japanese patients with rheumatoid arthritis.
1/2015	Predicting joint destruction in rheumatoid arthritis with power Doppler, anti-citrullinated peptide antibody, and joint swelling.
5/2012	Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryusuke Yoshimi Research Topics

Disease

14	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2024 - 01/2012
10	Inflammation (Inflammations) 03/2023 - 03/2006
6	Rheumatoid Arthritis 05/2023 - 05/2012
5	Neoplasms (Cancer) 02/2024 - 01/2021
4	VEXAS syndrome 10/2023 - 11/2021
4	Infections 01/2023 - 09/2020
4	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 01/2012
3	Arthritis (Polyarthritis) 10/2022 - 11/2021
3	Disease Progression 01/2022 - 02/2003
3	Relapsing Polychondritis 01/2022 - 01/2021
2	Adult-Onset Still's Disease 12/2023 - 01/2021
2	Anemia 10/2023 - 04/2023
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 01/2022
2	Thrombocytopenia (Thrombopenia) 04/2023 - 08/2022
2	Systemic Scleroderma (Systemic Sclerosis) 03/2023 - 01/2022
2	Arthralgia (Joint Pain) 01/2023 - 01/2021
2	Ulcer 10/2022 - 10/2016
2	Oral Ulcer (Mouth Ulcer) 10/2022 - 07/2021
2	Myocarditis (Carditis) 01/2022 - 01/2021
2	Rheumatic Diseases (Rheumatism) 01/2022 - 01/2021
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2021
2	Necrosis 01/2022 - 07/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2020 - 01/2016
1	Diabetes Mellitus 02/2024
1	Behcet Syndrome (Behcet's Syndrome) 01/2024
1	Macrophage Activation Syndrome 12/2023
1	Macrocytic Anemia 10/2023
1	Neutropenia 04/2023
1	Immune Reconstitution Inflammatory Syndrome 03/2023
1	Paresis (Hemiparesis) 03/2023
1	Skin Ulcer 10/2022
1	Erythema Nodosum 10/2022
1	Oral Manifestations 10/2022
1	Fibrosis (Cirrhosis) 08/2022
1	POEMS Syndrome (Syndrome, POEMS) 08/2022
1	Polyneuropathies (Polyneuropathy) 08/2022
1	Edema (Dropsy) 08/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022
1	Eosinophilia 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Paralysis (Palsy) 01/2022
1	Ischemia 01/2022
1	Bone Fractures (Bone Fracture) 01/2022
1	Familial Mediterranean Fever (Periodic Disease) 12/2021
1	Carotid Artery Diseases 11/2021
1	Atherosclerosis 11/2021
1	Nausea 07/2021
1	Hypertension (High Blood Pressure) 06/2021

Drug/Important Bio-Agent (IBA)

7	GlucocorticoidsIBA 02/2024 - 01/2021
6	Prednisolone (Predate)FDA LinkGeneric 10/2023 - 09/2020
5	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2012
4	EnzymesIBA 10/2023 - 01/2021
4	AntibodiesIBA 11/2021 - 01/2012
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2024 - 01/2021
3	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2021
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 01/2021
3	AutoantibodiesIBA 11/2021 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2020
3	AutoantigensIBA 11/2021 - 01/2012
3	IntegrinsIBA 02/2014 - 05/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 01/2022
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2024 - 10/2023
2	Abatacept (Orencia)FDA Link 05/2023 - 11/2021
2	Peptides (Polypeptides)IBA 05/2023 - 01/2015
2	LigandsIBA 04/2023 - 01/2021
2	ORALIT (ORS)IBA 04/2023 - 01/2023
2	apremilastIBA 10/2022 - 07/2021
2	InterferonsIBA 08/2022 - 11/2018
2	tocilizumab (atlizumab)FDA Link 01/2022 - 11/2021
2	CytokinesIBA 11/2021 - 01/2020
2	Interferon Type IIBA 11/2021 - 10/2018
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2014
1	Calcineurin InhibitorsIBA 02/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2024
1	Interleukin-1 (Interleukin 1)IBA 12/2023
1	Interleukin-6 InhibitorsIBA 12/2023
1	cyclic citrullinated peptideIBA 05/2023
1	AntigensIBA 03/2023
1	C-Reactive ProteinIBA 08/2022
1	Reticulin (Reticular Fiber)IBA 08/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	mepolizumabIBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Denosumab FDA Link 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	PyrinIBA 12/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2021
1	Colchicine FDA LinkGeneric 07/2021
1	LDL CholesterolIBA 06/2021

Therapy/Procedure

5	Therapeutics 04/2023 - 02/2003
1	Stem Cell Transplantation 03/2023
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Activities of Daily Living (ADL) 01/2022